Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer.
No Thumbnail Available
Embargo End Date
ICR Authors
Authors
Comino-Mendez, I
Turner, N
Turner, N
Document Type
Journal Article
Date
2017-12
Date Accepted
2017-10-11
Abstract
Advances in circulating tumor DNA (ctDNA) analysis are revealing new treatment strategies for patients with cancer. Detection of residual disease with ctDNA analysis predicts relapse with high accuracy after treatment for early-stage lung cancer. Cancer Discov; 7(12); 1368-70. ©2017 AACRSee related article by Chaudhuri et al., p. 1394.
Citation
Cancer discovery, 2017, 7 (12), pp. 1368 - 1370
Source Title
Publisher
ISSN
2159-8274
eISSN
2159-8290
Collections
Research Team
Molecular Oncology